Digital Genetics Threatens Seed Sovereignty and Farmers’ Rights

Digital Genetics Threatens Seed Sovereignty and Farmers’ Rights

At the 11th session of the International Treaty on Plant Genetic Resources for Food and Agriculture (ITPGRFA) in Lima, Peru, one issue has emerged as particularly divisive: Digital Sequence Information (DSI). For biodiversity-rich countries like India, the debate goes beyond scientific progress—it touches the core of agricultural sovereignty and equity. Despite facilitating genome sequencing and crop improvement, DSI has raised alarm over the creeping monopolization of genetic resources. The potential for corporations to bypass benefit-sharing obligations under international treaties has brought the adequacy of existing frameworks into sharp focus.

Policy Instruments at the Center

DSI refers to genetic material extracted from DNA, RNA, and proteins, stored and analyzed digitally to aid research and innovation. This technology underpins critical advancements, including genome editing for crop resilience and biodiversity monitoring. However, the issue is the legal ambiguity surrounding digital genetic data. While treaties like the Convention on Biological Diversity (CBD), the Nagoya Protocol, and the ITPGRFA mandate benefit-sharing mechanisms, none explicitly address DSI in the digital realm. This legal vacuum allows companies to patent genomic discoveries derived from DSI without compensating source communities.

• Under the ITPGRFA’s Multilateral System (MLS), over 2.3 million exchanges of plant genetic resources have been facilitated. Yet, financial benefits flowing to farmers remain negligible—less than $40 million in benefit-sharing funds globally.
• The Nagoya Protocol lacks provisions for transnational digital data transfer, further complicating enforcement.
• Genomic databases are disproportionately housed in developed countries or controlled by large corporations, exposing developing nations to systemic inequity.

The Case For Digital Sequence Information

Advocates of DSI argue that it democratizes scientific research. Researchers worldwide now access genetic data without needing physical samples, accelerating progress in precision agriculture and biodiversity conservation. For example, genome sequencing enabled the rapid identification of pathogens during the COVID-19 pandemic, illustrating the transformative potential of DSI in public health.

In agriculture, DSI facilitates genome mapping technologies that enhance drought resistance and crop yields—essential in climate-stressed regions. According to a study by the International Maize and Wheat Improvement Center, precision genome editing increased wheat yields by 14% in trial settings, results that would be hard to replicate without DSI.

The open access model, which many scientific bodies advocate, is particularly critical here. Restricting the sharing of DSI could slow down innovation globally, placing developing countries, where genomic infrastructure is still nascent, at a structural disadvantage.

The Case Against DSI and its Institutional Blind Spots

The strongest critique of the current DSI governance lies in its inequity. Multinational corporations, primarily headquartered in developed nations, exploit genomic data to build proprietary intellectual capital while excluding farmers and indigenous communities whose resources form the bedrock of their innovation. Cases like Syngenta's patent on traits derived from African maize demonstrate the risks of biopiracy disguised as innovation.

The Multilateral System has failed to compensate farmers adequately. Despite millions of genetic exchanges, India, home to 7-8% of global biodiversity, has seen negligible monetary returns from its plant genetic resources. Rather than empowering local communities, DSI appears to consolidate control over genetic resources in a few powerful hands. This mirrors a broader trend across international treaties—where legal provisions fail to keep pace with technological reality.

The skepticism deepens when one examines the institutional weaknesses of enforcement. The National Biodiversity Authority (NBA), tasked with overseeing benefit-sharing in India, remains underfunded, receiving only ₹65 crore in annual budget for biodiversity governance—completely inadequate to address DSI misuse by corporations operating across jurisdictions.

International Comparison: Brazil’s Pragmatic Model

Brazil offers an intriguing counterpoint. Under its Biodiversity Law 2015, the country mandates benefit-sharing for the use of genetic resources, including penalties for non-compliance. Unlike India’s challenges with enforcement, Brazil has implemented digital traceability mechanisms to monitor the utilization of its genetic resources. According to the Brazilian Environment Ministry, fines exceeding $60 million have already been levied on corporations exploiting genetic material without compliance.

However, Brazil’s success is not absolute. The governance gap in regulating digital patents lingers, highlighting that even progressive models fall short of fully addressing DSI concerns.

Where Things Stand

The core issue remains unresolved: Can DSI reconcile open-access needs with equitable benefit-sharing? While its promise for scientific and agricultural advancement is undeniable, glaring regulatory gaps leave biodiversity-rich countries vulnerable to exploitation. India must lead efforts to overhaul global frameworks, ensuring DSI is explicitly integrated into the CBD and Nagoya Protocol.

Simultaneously, capacity-building measures like bolstering the NBA’s funding and implementing digital traceability tools should be prioritized domestically. Without structural change, DSI risks becoming yet another arena where technology amplifies inequities rather than mitigates them. For farmers, the stakes are existential.

Exam Integration

Practice Questions for UPSC

Prelims Practice Questions

Frequently Asked Questions